SCIENTURE HOLDINGS, INC. Gain (Loss) on Disposition of Business
SCIENTURE HOLDINGS, INC. (SCNX) had Gain (Loss) on Disposition of Business of $29.69 million as of 2024-02-16, per its 10-Q filed 2024-08-09.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfBusiness · last filed 2024-08-09
- 2024-02-16: Gain (Loss) on Disposition of Business $29.69M.
| Period end | Gain (Loss) on Disposition of Business |
|---|---|
| 2024-02-16 | $29.69M 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |